论文部分内容阅读
采用中西医结合疗法治疗原发性肝癌128例,80%以上有乙肝史,入院时60%已濒临死亡。小肝癌仅4例,切除6例均复发,故切除后不能认为是治愈。介入治疗仅2例生存三年以上。肝总动脉结扎经胃网膜右动脉插管,肝固有动脉灌注,加中医药治疗三年生存率31.8%,五年生存率23.6%。故防治肝炎,预防肝癌,早期发现小肝癌,切除加中医药治疗,可提高疗效。肝总动脉结扎灌注加中医药治疗是目前较好的方法。
Treatment of 128 cases of primary liver cancer with integrated traditional Chinese and Western medicine treatment, 80% of the history of hepatitis B, admission 60% already dying. Only 4 cases of small liver cancer, resection in 6 cases were relapsed, it can not be considered after resection of the cure. Interventional treatment only 2 cases survived more than three years. The common hepatic artery was ligated through the right gastric artery and intubated into the hepatic artery. The three-year survival rate was 31.8%. The five-year survival rate was 23.6%. Therefore, prevention and treatment of hepatitis, prevention of liver cancer, early detection of small liver cancer, resection plus Chinese medicine treatment can improve the curative effect. Ligation of the common hepatic artery plus traditional Chinese medicine treatment is the better method.